MedTrace Logo

FlowTriever Pulmonary Embolectomy Clinical Study

NCT02692586 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2021-05-24

Study results available
· View outcomes & findings →

Summary

Evaluate the safety and effectiveness of the FlowTriever System for use in the removal of emboli from the pulmonary arteries in the treatment of acute pulmonary embolism.

Conditions

  • Pulmonary Embolism
  • Acute Pulmonary Embolism
  • Submassive Pulmonary Embolism
  • Massive Pulmonary Embolism

Interventions

DEVICE

FlowTriever System

Sponsors & Collaborators

  • Inari Medical

    lead INDUSTRY

Principal Investigators

  • Kenneth Rosenfield, MD · Massachusetts General Hospital

  • Victor Tapson, MD · Cedars-Sinai Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-11-30
Completion
2017-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02692586 on ClinicalTrials.gov